J
Juan F. Viles-Gonzalez
Researcher at University of Miami
Publications - 76
Citations - 4278
Juan F. Viles-Gonzalez is an academic researcher from University of Miami. The author has contributed to research in topics: Atrial fibrillation & Catheter ablation. The author has an hindex of 29, co-authored 76 publications receiving 3805 citations. Previous affiliations of Juan F. Viles-Gonzalez include Icahn School of Medicine at Mount Sinai.
Papers
More filters
Journal ArticleDOI
In-Hospital Complications Associated With Catheter Ablation of Atrial Fibrillation in the United States Between 2000 and 2010 Analysis of 93 801 Procedures
Abhishek Deshmukh,Nileshkumar J. Patel,Sadip Pant,Neeraj Shah,Ankit Chothani,Kathan Mehta,Peeyush Grover,Vikas Singh,Srikanth Vallurupalli,Ghanshyambhai T. Savani,Apurva Badheka,Tushar Tuliani,Kaustubh Dabhadkar,George Dibu,Y. Madhu Reddy,Asif Sewani,Marcin Kowalski,Raul Mitrani,Hakan Paydak,Juan F. Viles-Gonzalez +19 more
TL;DR: There was a significant association between operator and hospital volume and adverse outcomes and a need for future research into identifying the safety measures in AF ablations and instituting appropriate interventions to improve overall AF ablation outcomes.
Journal ArticleDOI
The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.
Juan F. Viles-Gonzalez,Saibal Kar,Pamela S. Douglas,Srinivas R. Dukkipati,Ted Feldman,Rodney Horton,David R. Holmes,Vivek Y. Reddy +7 more
TL;DR: In this paper, the authors investigated the frequency and clinical impact of incomplete left atrial appendage sealing and consequent peri-device residual blood flow in patients undergoing percutaneous LAA closure with the Watchman device.
Journal ArticleDOI
Contemporary Trends of Hospitalization for Atrial Fibrillation in the United States, 2000 Through 2010 Implications for Healthcare Planning
Nileshkumar J. Patel,Abhishek Deshmukh,Sadip Pant,Vikas Singh,Nilay Patel,Shilpkumar Arora,Neeraj Shah,Ankit Chothani,Ghanshyambhai T. Savani,Kathan Mehta,Valay Parikh,Ankit Rathod,Apurva Badheka,James Lafferty,Marcin Kowalski,Jawahar L. Mehta,Raul D. Mitrani,Juan F. Viles-Gonzalez,Hakan Paydak +18 more
TL;DR: In this article, the authors examined the trends of atrial fibrillation-related hospitalizations in the United States and compared patient characteristics, outcomes, and comorbid diagnoses.
Journal ArticleDOI
Atherothrombosis: A widespread disease with unpredictable and life-threatening consequences
TL;DR: Recent evidence suggests that inhibition of tissue factor or elements in the tissue factor pathway (i.e., factors VIIa and Xa, or thrombin) has the potential to further improve outcomes in atherothrombosis.
Journal ArticleDOI
Effects of Aggressive Versus Conventional Lipid-Lowering Therapy by Simvastatin on Human Atherosclerotic Lesions: A Prospective, Randomized, Double-Blind Trial With High-Resolution Magnetic Resonance Imaging
Roberto Corti,Valentin Fuster,Zahi A. Fayad,Stephen G. Worthley,Gérard Helft,William F. Chaplin,Jörg Muntwyler,Juan F. Viles-Gonzalez,Jesse Weinberger,Donald A. Smith,Gabor Mizsei,Juan J. Badimon +11 more
TL;DR: Effective and protracted lipid-lowering therapy with simvastatin is associated with a significant regression of atherosclerotic lesions.